Summary Clonal subpopulations of different ploidy values and metastatic capacities, isolated from the RIF-1 mouse sarcoma, have been tested for in vitro X-radiation sensitivity, for in vitro sensitivity to adriamycin and for in vitro and in vivo sensitivity to melphalan and CCNU. Following X-radiation, no consistent differences in the survival curve characteristics (Do and n) of diploid, tetraploid and octoploid cells were observed. In addition no relationship between radiation response and metastatic capacity was observed. For drug response, no marked differences were found in the dose response curves of RIF-1 clones treated in vitro with adriamycin. However, a wide variation in the responses of RIF-I clones to in vitro melphalan treatment was observed which was independent of both ploidy and metastatic capacity. Although the responses of RIF-1 clones to in vitro CCNU treatment were similarly independent of metastatic capacity, a clear relationship between CCNU sensitivity and ploidy was observed. Thus, all diploid RIF-l clones were markedly more sensitive to CCNU treatment than either tetraploid or octoploid RIF-l clones. For both melphalan and CCNU treatment the relative sensitivities in vitro correlated with in vivo sensitivities as assayed by clonogenic cell survival.
A major focus of interest in studies of tumour cell heterogeneity has been the implications of such heterogeneity for metastatic behaviour and therapeutic response. Numerous studies have demonstrated the presence within primary tumours of cells with differing metastatic ability (for review, Poste & Fidler, 1980) and with different susceptibilities to cytotoxic agents (Hakansson & Trope, 1974a,b; Palyi et al., 1977; Heppner et al., 1978) . Furthermore, differences in drug response between cells populating metastases and those isolated from the localized "primary" tumour have also been reported (Tsuruo & Fidler, 1981) .
Many tumour cell populations are also known to be heterogeneous with respect to chromosome number and DNA content (Stich, 1960; Spooner & Cooper, 1972; Nowell, 1976; Suzuki et al., 1977) . Although the relationship between DNA content and metastasizing ability has been the subject of several investigations (Suzuki et al., 1978; , few studies have addressed the relationship between ploidy and response to cytotoxic drugs. Since many agents currently used in cancer therapy interact directly or indirectly with DNA, we have carried out such a study using the RIF-1 mouse sarcoma.
By means of flow cytometry and chromosome analysis the RIF-1 tumour has been shown to be comprised of both diploid and tetraploid subpopulations of clonogenic tumour cells Correspondence: J.G. Reeve.
Received 6 February 1983; accepted 22 March 1983. (Twentyman et al., 1980) . In the previous paper, (Reeve & Twentyman, this issue) we described how clonal variants with differing ploidy levels, including diploid, tetraploid and octoploid values, were isolated from the parent RIF-1 tumour by in vitro cloning. The metastasizing capacities of the subpopulations of differing ploidy were established using an experimental metastasis assay. Isolation of RIF-1 clonal lines of defined ploidy and metastatic ability allows an evaluation of the influence of these 2 parameters on therapeutic response. In the present study, we have assessed the in vivo and in vitro sensitivities of clonal variants of different ploidy values and of different metastatic abilities to the drugs Adriamycin, CCNU and Melphalan, together with their in vitro sensitivity to x-radiation.
Materials and methods

Mice
C3H/Km mice bred in this unit were used in all experiments. This colony was derived from breeding pairs imported from the C3H/Km colony Stanford University, California in which the RIF-1 tumour arose (Twentyman et al., 1980) . Animals were age and sex matched within each experiment.
Tihmour cell lines
The details of the derivation of the RIF-1 tumour, the in vitro cloning procedures and the selection of metastatic variants as defined by the lung colony ©) The Macmillan Press Ltd., 1983 assay are described in the previous paper (Reeve & Twentyman, 1983) . The details of flow cytometry have been described elsewhere (Reeve & Twentyman, 1982) .
The ploidy levels, lung colony formation efficiencies and the in vitro doubling times of the RIF-1 clonal variants used in the present study are summarized in Table I . & Twentyman, 1983. 3Calculated from the slope of the growth curve for cells in the exponential phase of growth.
In vitro radiation sensitivity RIF-1 clonal variants of different ploidy levels and metastatic abilities were exposed to single doses of x-radiation ranging from 1.5-16.5 Gy during log phase monolayer culture in 25 cm2 tissue culture flasks (Sterilin) containing Eagles Minimal Essential Medium with Earle's salts supplemented with 10% newborn calf serum (both Gibco Biocult Ltd.) and antibiotics. Immediately after irradiation, the cells were removed from the tissue culture flasks using trypsin as previously described (Twentyman et al., 1980) , counted and various cell numbers were plated into replicate petri dishes containing medium. Colonies were incubated for 13 days, then fixed and stained with crystal violet. Colonies containing > 50 cells were counted by means of a dissecting microscope.
A computer program (Watson, 1978) was used to derive the survival parameters Do and n according to a linear transform of the multitarget, single hit radiation survival curve.
In vitro drug sensitivity RIF-I clones, growing in log phase monolayer culture in 25cm2 tissue culture flasks, were exposed to appropriate concentrations of the drug under study for 1 h. Adriamycin (Pharmitalia Ltd., Italy) was dissolved in sterile PBS, CCNU (Lundbeck Ltd., Luton) in absolute ethanol and melphalan (Burroughs Wellcome Co., London) in acid ethanol. All drugs were prepared immediately before use and added to the 5 ml of medium overlying the cells in a volume of 0.1 ml. As a control for each drug under study 0.1 ml of the appropriate vehicle alone was added to similar cultures. Immediately after treatment the cells were rinsed twice, trypsinized, counted and plated into replicate petri dishes as described above. Colonies were incubated for 13 days and counted.
In vivo drug sensitivity Tumours were established from RIF-1 clones by inoculating 105 cells into the gastrocnemius muscle of the hind leg. Tumours were treated when they had reached -volume of 300-600 mm3. Each mouse was ear tagged, assigned to treatment groups on a random basis and treated individually, Immediately before use CCNU was dissolved in absolute ethanol, diluted 1:20 in 0.5% carboxymethyl cellulose/Hanks Balanced Salt Solution (HBSS). Prior to injection melphalan was dissolved in acidified ethanol, diluted 1: 10 in propylene glycol-K2HPO4 buffer. Appropriate concentrations of either CCNU or melphalan were injected i.p. Control mice received appropriate volumes of vehicle alone.
Clonogenic cell survival Tumour bearing mice were killed 24 h after treatment. Two tumours from mice receiving the same drug treatment were aseptically excised, pooled, weighed and disaggregated to yield single cell suspensions as previously described (Reeve & Twentyman, 1982) . Various cell numbers of each suspension were plated into triplicate petri dishes and the cell colonies were counted 13 days later. Cell killing in vivo was expressed as surviving fraction (SF).
SF =number of colonies formed by 100 cells from treated tumour number of colonies formed by 100 cells from untreated tumour Results X-ray responses of parent RIF-1 cells and clonal sublines Figure 1 shows that the x-ray survival curves typically obtained for the parent RIF-1 tumour and the clonal sublines of differing ploidy levels are the clones and their in vitro response to CCNU (Table II) . The data shown in Figure 6 and Table II show that the in vitro sensitivity to CCNU treatment exhibited by the diploid clone 28 similarly characterizes diploid clones 2 and 23. Clone 19 was Table I . 2See Figure 5 . 3See Figure 4 . used as a standard throughout these experiments ( Figure 5 ) to typify the relative resistance of tetraploid clones to CCNU treatment. Figure 7 shows that over the dose range studied, cell survival in vitro in the presence of CCNU was similar for tetraploid clone 20 and octoploid clone 21. Both are markedly more resistant to CCNU treatment than diploid clone 28. However, octoploid clone 21 is no more resistant to in vitro treatment with CCNU than tetraploid clone 20.
In vivo sensitivity of RIF-I clones to chemotherapeutic agents We have examined whether the observed clonal variation in response to melphalan and CCNU treatment in vitro was also detectable in vivo. (b) CCNU Figure 9 shows data for the in vitro cell survival response of RIF-1 clones treated in vivo with CCNU. Within the range of doses studied diploid clone 28 was most sensitive to CCNU treatment with tetraploid clones 16, 19 and 20 being considerably less sensitive.
Discussion
We have examined the effect of ploidy and metastatic ability on the responses of RIF-1 clonal subpopulations to x-radiation and cytotoxic agents. A number of clinical observations (De, 1961; Atkin et al., 1959) as well as some in vivo and in vitro radiobiological studies (Revesz & Norman, 1960; Puck, 1960; Berry, 1963) number and ploidy of cells having diploid, tetraploid or octoploid values. Our findings are in agreement with other in vitro studies (Till, 1961; Lockart et al., 1961; Rommelaire & Errera, 1972; Limbosh et al., 1974; Millar & Millar, 1977) which indicate that chromosome number per se does not correlate with radiation response.
For drug response, no significant differences in the dose response curves of RIF-1 clones treated with adriamycin was observed. However, our data demonstrate wide variation in the responses of RIF-1 clones to in vitro melphalan and CCNU treatment. Furthermore, the relative sensitivities in vitro are correlated with in vivo sensitivities in terms of clonogenic cell survival assayed in vitro. This latter finding contrasts with lack of correlation between in vitro and in vivo drug sensitivities observed for tumour cell subpopulations derived from a mammary adenocarcinoma (Heppner et al., 1978) .
The clonal variation in drug sensitivity observed for melphalan is independent of ploidy. Thus, the (Hakansson & Trope, 1974a,b; Palyi et al., 1977; Heppner et al., 1978; Tsuruo & Fidler, 1981) no-one to our knowledge, has reported ploidy-dependent drug responses. No correlation, however, between drug response and metastatic ability was observed for the RIF-1 clones examined in the present study. Our data show that there is no correlation between the growth kinetics of the clones and their drug sensitivities. This finding is in agreement with similar observations (Hakansson & Trope, 1973; Van Putten, 1974) which also suggest that differences in clone sensitivity to drug treatment are not likely to be explained by small differences in cell proliferation. We are currently examining CCNU and melphalan transport in cells of RIF-1 subpopulations which differ in their sensitivities to these agents, together with DNA repair properties, in an attempt to elucidate the cellular differences responsible for the diverse responses of RIF-1 clones to these agents. 
